On August 6, Centene fell 5.11% in regular trading, trading at $63.535/share with turnover of approximately $96.61 million, fully erasing the prior session's 5.06% gain.

On the news front, despite multiple investment banks raising price targets and Q2 adjusted EPS of $2.51 significantly beating the $1.08 consensus estimate, RBC Capital highlighted that approximately $0.50 of Q2 adjusted EPS was attributable to non-recurring settlement items, raising concerns about underlying earnings quality. Additionally, management indicated that Medicaid profit margins may not meaningfully recover until H2 2027, while lowering its Medicaid membership forecast to an 8%-9% year-over-year decline from the previously expected 6% decline.

The broader managed healthcare sector traded under pressure, with UnitedHealth down 2.16%, Humana down 2.01%, Molina Healthcare down 1.96%, and Elevance Health down 1.09%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)